Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of apraglutide in short bowel syndrome with intestinal failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Apraglutide (apraglutide)

Snippet

Sponsor: VectivBio AG | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED